Form 4: Supernus Pharmaceuticals CFO Timothy Dec Reports Stock Disposals for Tax Obligations

Timothy Dec, CFO of Supernus Pharmaceuticals, reported the disposal of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On March 5, 2025, Timothy C. Dec, Senior Vice-President & CFO of Supernus Pharmaceuticals, Inc., reported the disposal of common stock to cover tax withholding requirements.
• A total of 3,193 shares of common stock were disposed of at a price of $33.05 per share.
• These disposals were related to the vesting of Restricted Stock Units.
• Following these transactions, Dec directly owns 10,898 shares of Supernus Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock transactions for tax purposes. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The disposal of shares by a company executive can sometimes be perceived negatively by shareholders, but in this case, it is a routine transaction to cover tax obligations.

Key Dates